“…Despite increased utilization of pharmacological2, 3, 4, 5, 6, 7, 8, 9 and device therapy options10, 11, 12, 13 that improve clinical outcomes in randomized controlled trials, morbidity and mortality in HF remain a major burden to patients, their caregivers, and national healthcare systems. Patients with HF frequently experience worsening symptoms related to accumulation of excess intravascular volume and congestion, requiring hospitalization to provide intravenous medical support to restore normal volume 14, 15, 16, 17, 18, 19. Heart failure is cited as the most frequent cause of hospitalization in the US Medicare population, resulting in >1 million admissions per year (accounting for 1–2% of all hospitalizations) 20, 21.…”